Truist Financial
COLL icon

Truist Financial’s Collegium Pharmaceutical COLL Stock Holding History

Truist Financial’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Buy
10,560
+2,711
+35% +$92.6K ﹤0.01% 2389
2026
Q1 		$260K Buy
7,849
+3,521
+81% +$149K ﹤0.01% 2484
2025
Q4 		$200K Buy
+4,328
New +$181K ﹤0.01% 2606

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Truist Financial's COLL Position: Q2 2026 in Review

Truist Financial increased its Collegium Pharmaceutical (COLL) stake by 35% in Q2 2026, buying an estimated $92.6K and bringing the position to 10,560 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

Truist Financial first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Truist Financial held 10,560 shares of Collegium Pharmaceutical worth $382K as of Q2 2026.
  • Truist Financial bought 2,711 Collegium Pharmaceutical shares in Q2 2026, an estimated $92.6K.
  • Collegium Pharmaceutical made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2389 holding.
  • Truist Financial first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.